MedPath

Intelligent Pain Management System for Assessing Pain in Cancer Patients

Not Applicable
Completed
Conditions
Pain
Neoplasms
Registration Number
NCT02765269
Lead Sponsor
Xinhua Translational Institute for Cancer Pain, Shanghai
Brief Summary

The purpose of this study is to determine whether the Intelligent Pain Management System (IPMS) could make recording and interfering pain timely among cancer patients with pain. The system's usability, feasibility, compliance, and satisfaction will also be assessed.

Detailed Description

Research indicate that over one-third of cancer patients experienced cancer pain, which is known as a major reason leading to lower quality of life of the patients.In this present study, the investigators aim to design, develop, and test the feasibility of a low cost, conveniently implemented mobile application to facilitate real-time pain recording and timely intervention among Chinese cancer patients with pain. This system evaluate real-time pain and Karnofsky Performance Status(KPS)scores for quality of life, and to generate an action plan to visit the physician or to adjust pain medication dosage when the pain threshold is reached. The investigators study is to test this system's effectiveness.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • the patient was able to read Chinese and use smart phones;
  • the patient was diagnosed with cancer and has self-reported cancer pain within a month prior to the study;
  • the patient was being seen on a regular basis by the oncology team;
  • the patient was under standard analgesia treatments;
  • the patient was estimated to have over 3 months survival time.
Exclusion Criteria
  • the patients who self-reported to have severe cognitive impairments or major comorbid illnesses that would interfere with pain assessment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Feasibility of Mobile Application Assessed by Observing the Number of Daily Pain Assessments Recorded Among Patients2 weeks

The primary objective is to demonstrate that this mobile application is feasible by observing the numbers of daily pain assessment among patients.

Secondary Outcome Measures
NameTimeMethod
Karnofsky Performance Score Evaluation2 weeks

The Karnofsky performance score runs from 100 to 0, where 100 is "perfect" health and 0 is death. Higher values represent better outcomes.The investigators will compare average score between trial group and control group.

Pain Management2 weeks

Numerical rating scale allows a person to describe the intensity of his/her pain as a number usually ranging from 0 to 10, where "0" means "no pain" and "10" means pain as "bad as it could be". Higher values means worse outcomes. The investigators will compare average pain score assessed by numerical rating scale at the end of the trial period.

Users' Satisfaction (Questionnaire)2 weeks

Patients will be asked to complete a questionnaire after patients use it for 2 weeks.

Trial Locations

Locations (1)

Xinhua Translational Institute for Cancer Pain, Shanghai

🇨🇳

Shanghai, Shanghai, China

Xinhua Translational Institute for Cancer Pain, Shanghai
🇨🇳Shanghai, Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.